Literature DB >> 30925359

Neuronal intranuclear inclusion disease showing blepharoptosis and positive serum anti-acetylcholine receptor antibody without myasthenia gravis.

Koji Hayashi1, Tsuyoshi Hamaguchi2, Kenji Sakai3, Keiko Nakamura4, Koichi Wakabayashi5, Hiroe Shirasaki6, Masahito Yamada7.   

Abstract

Entities:  

Keywords:  Anti-acetylcholine receptor antibody; Myopathy and blepharoptosis; Neuronal intranuclear inclusion disease

Mesh:

Substances:

Year:  2019        PMID: 30925359     DOI: 10.1016/j.jns.2019.03.013

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


× No keyword cloud information.
  2 in total

Review 1.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

Review 2.  Clinical and mechanism advances of neuronal intranuclear inclusion disease.

Authors:  Yueqi Liu; Hao Li; Xuan Liu; Bin Wang; Hao Yang; Bo Wan; Miao Sun; Xingshun Xu
Journal:  Front Aging Neurosci       Date:  2022-09-13       Impact factor: 5.702

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.